<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75708">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02118844</url>
  </required_header>
  <id_info>
    <org_study_id>2014-000289-23</org_study_id>
    <nct_id>NCT02118844</nct_id>
  </id_info>
  <brief_title>Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions</brief_title>
  <acronym>BaChi-BloPro1</acronym>
  <official_title>Laparoscopic Bariatric Surgery: Impact of the Level of Neuromuscular Blockade on Surgical Conditions - Comparison Between Moderate and Deep Neuromuscular Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether deep neuromuscular blockade  compared to
      moderate neuromuscular blockade may improve the surgical conditions in patients undergoing
      laparoscopic bariatric surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Improvement of surgical conditions</measure>
    <time_frame>15 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The surgical conditions will be evaluated with the King Score (M. King et al Anesthesiology 2000; 93: 1392 - 97). This score is a 4-point score. The evaluation will be done by the surgeon who is blinded. An improvement of at least 1-point will be considered as clinical relevant.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pneumoperitoneum generated pressure</measure>
    <time_frame>15 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Concomitantly to the evaluation of the surgical conditions the pneumoperitoneal pressure (in mm Hg) generated by the Carbon dioxide insufflation will be registrated.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>time needed to perform gastrojejunal anastomosis</measure>
    <time_frame>90 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The time from begin of the gastrojejunal anastomosis until the end will be measured in min. The surgeon indicate begin and end of the gastrojejunal anastomosis.</description>
  </other_outcome>
  <other_outcome>
    <measure>10 point-VAS to evaluate surgical conditions</measure>
    <time_frame>2 x 15 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>Concomitantly the the evaluation by the King score, the surgical conditions will be also evaluated by a 10 point VAS (visual-analog scale).This evaluation will also be realized by the surgeon, still blinded to the study arm.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Bariatric Surgery</condition>
  <condition>Laparoscopic Bariatric Surgery</condition>
  <condition>Robotic Bariatric Surgery</condition>
  <condition>Gastric Bypass</condition>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Moderate rocuronium neuromuscular blockade</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>rocuronium bolus is given if needed to maintain moderate neuromuscular blockade (TOF-count 2-4) during gastrojejunal anastomosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>deep rocuronium neuromuscular blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rocuronium bolus is given if needed to maintain deep neuromuscular blockade (here defined as a Posttetanic Count 1 - 5) during gastrojejunal anastomosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rocuronium</intervention_name>
    <arm_group_label>Moderate rocuronium neuromuscular blockade</arm_group_label>
    <arm_group_label>deep rocuronium neuromuscular blockade</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient between 18 and 64 years

          -  indication for bariatric surgery accordingly to HAS

          -  patient undergoing laparoscopic or robotic gastric bypass surgery

          -  written informed consent

          -  affiliation to social security

        Non-inclusion Criteria:

          -  known hypersensibility to any of the drugs used during this study

          -  absence of written informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Fuchs-Buder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nancy, Department of Anaesthesia &amp; Critical Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Fuchs-Buder, MD</last_name>
    <phone>#33.383.153942</phone>
    <email>t.fuchs-buder@chu-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Nancy/Brabois</name>
      <address>
        <city>Vandoeuvre-Les-Nancy</city>
        <zip>F-54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Fuchs-Buder, MD</last_name>
      <phone>#33.383.153942</phone>
      <email>t.fuchs-buder@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas Fuchs-Buder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claude Meistelman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent Brunaud, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denis Schmartz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie Jacques, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thibaut Fouquet, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Serradoni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire Nominé, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>April 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>surgical conditions</keyword>
  <keyword>deep neuromuscular blockade</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
